NORDIC Clinicial Trials

The Neuro-Ophthalmology Research Disease Investigator Consortium (NORDIC) is a cohesive and extensive group of Neuro-Ophthalmologists, other doctors, coordinators, biostatisticians, clinical trial experts and reading centers, who have developed a structured organization to perform prospective clinical research with the support of the National Eye Institute of the NIH, other funding agencies, and industry.

Mission Statement

The Neuro-Ophthalmology Research Disease Investigator Consortium (NORDIC) is a cohesive extensive group of Neuro-Ophthalmologists and other doctors, who have developed a structured organization to perform prospective clinical research with the support of the National Eye Institute of the NIH, other funding agencies, and industry. Neuro-Ophthalmology is a subspecialty of Neurology and Ophthalmology that addresses scientific and medical aspects that bridge both specialties.  There is a broad spectrum of Neuro-Ophthalmologic disorders that collectively affect millions of people. Many of these are visual disorders associated with other systemic or neurological conditions. Almost all of these fit the US Government definition as “rare” diseases. While some affect larger numbers of people (e.g., optic neuritis in multiple sclerosis), most affect fewer individuals (e.g. idiopathic intracranial hypertension, nonarteritic anterior ischemic optic neuropathy, thyroid eye disease) and have infrequently been the subject of prospective research.  Thus, there is often little consensus among practitioners on the diagnostic evaluation or therapy for many Neuro-Ophthalmological disorders.   

NORDIC was created, to provide the organization and operational capability to address these and other crucial unanswered questions and pursue new clinical trial research over a broad range of scientific and medical issues that affect vision, eye movements, pupil function and visual quality of life.  NORDIC performs multi-site observational and treatment trials that concern disease risk, diagnosis, treatment and other management-aspects of those disease entities or new therapies, which could not be studied without a clinical research organization. 

NORDIC provides:

  1. Strong centralized leadership and administration;
  2. Study development, management, coordination, and analyses.
  3. Experienced clinical sites/investigators/coordinators.
  4. Steering committees for all aspects of clinical trials.
5841 Cedar Lake Road · Suite 204 | Minneapolis, MN 55416
952.646.2037 info@nanosweb.org
meetings@nanosweb.org
© 2018 North American Neuro-Ophthalmology Society.
All Rights Reserved. Site by The Lone Designer
Terms of Service | Privacy Policy | Contact Us
As a result of General Data Protection Regulation (GDPR), our Privacy Policy and Terms of Service have been updated to better explain our relationship with you.
If you wish to opt in/out of receiving NANOS communication, please update your Member Profile.
Search Link
image widget
NANOS IN THE NEWS

NANOS Spotlight - September issue now available on the NANOS website.

Congrats to Drs. Deborah I Friedman, Peter A Quiros, Luis J Mejico, Prem Subramanian, Michael Wall and the NORDIC IIHTT Study Group, whose article titled Headache in Idiopathic Intracranial Hypertension: Findings From the Idiopathic Intracranial Hypertension Treatment Trial  was selected for the Members’ Choice Award for the Best Headache Article.

NANOS members have successfully presented a poster on Neuro-Ophthalmology Fellowships and Careers at the AAN Faculty and Trainee Reception at the AAN 2018 Annual Meeting.

Are you in search of a Neuro-Ophthalmology fellowship? Please visit our Fellowship page for openings.